# OnCo record nct04384484 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04384484/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04384484", "NCT04384484" ;
  schema:name "Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lym"@en ;
  schema:alternateName "LOTIS-5"@en ;
  schema:description "A phase 3 trial of Loncastuximab tesirine, Rituximab, Gemcitabine in diffuse large b-cell lymphoma, run by ADC Therapeutics S.A., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04384484/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04384484> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-09-16" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/zynlonta/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/capox/> ;
  onco:companies <https://onco.cc/companies/adc-therapeutics/> .